Evidence map›Paper›PMID 29596361›Full record

Trial reportNutrients2018

Optimal Serum Ferritin Levels for Iron Deficiency Anemia during Oral Iron Therapy (OIT) in Japanese Hemodialysis Patients with Minor Inflammation and Benefit of Intravenous Iron Therapy for OIT-Nonresponders.

Kazuya Takasawa, Chikako Takaeda, Takashi Wada, Norishi Ueda

Open access · goldAbstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Biomarkers of iron metabolism in chronic kidney disease.International urology and nephrology · 2021
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kazuya TakasawaDepartment of Internal Medicine, Division of Nephrology, Public Central Hospital of Matto Ishikawa, Ishikawa 9248588, Japan. kazuya@takasawa.org.
Chikako TakaedaDepartment of Internal Medicine, Division of Nephrology, Public Central Hospital of Matto Ishikawa, Ishikawa 9248588, Japan. takaeda@imcc-med.com.
Takashi WadaDepartment of Nephrology, Kanazawa University; Kanazawa, Ishikawa 9208641, Japan. twada@m-kanazawa.jp.
Norishi UedaDepartment of Pediatrics, Public Central Hospital of Matto Ishikawa, Ishikawa 9248588, Japan. nueda@mattohp.com.
Public Central Hospital of Matto Ishikawa · JPKanazawa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Administration, IntravenousAdministration, OralAdultAgedAnemia, Iron-DeficiencyFemaleFerric CompoundsFerric Oxide, SaccharatedFerritinsFerrous CompoundsGlucaric AcidHematinicsHumansIronKidney Failure, ChronicMaleFerric CompoundsFerric Oxide, SaccharatedFerritinsFerrous Compoundsferrous fumarateGlucaric AcidHematinicsIronTrace Elementsferritinhemodialysishepcidin-25inflammationiron deficiency anemiaoral iron therapy

Identifiers

PMID29596361
PMCPMC5946213
OpenAlexW2794826801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.